December 9, 2024 Uncategorized BetterLife Announces Favorable Outcome in New York Legal Claims Read More
November 25, 2024 Uncategorized BetterLife Obtains Favourable Cardiac Safety Data for BETR-001 Read More
October 23, 2024 Uncategorized BetterLife Obtains Favourable Genotoxicity Data for Oral BETR-001 Read More
August 29, 2024 Uncategorized BetterLife Announces Fully Subscribed Private Placement Financing Read More
August 27, 2024 Uncategorized BetterLife Highlights Advantages of Non-hallucinogenic LSD Derivative BETR-001 and Publication of its Methods to Treat Mood Disorders Patent Read More
July 16, 2024 Uncategorized Amendment of Disclosures in Past Management Information Circulars Read More
June 26, 2024 Uncategorized BetterLife To Present BETR-001 Preclinical Data at the 2024 Conference of the Federation of European Neuroscience Societies (FENS) in Vienna, Austria Read More
May 14, 2024 Uncategorized BetterLife Obtains Excellent Animal Cardiopulmonary Safety Data for Oral BETR-001 Read More
